NRSN Stock Latest News
Company AnnouncementsNeuroSense Therapeutics Moves to Early PrimeC Commercialization in U.S.5d ago6KNRSN
Company AnnouncementsNeuroSense Files U.S. Patent to Extend PrimeC into Traumatic Brain Injury1w ago6KNRSN
Company AnnouncementsNeuroSense Wins Nasdaq Hearing Date as PrimeC Nears Key Regulatory and Funding Milestones2w ago6KNRSN
Company AnnouncementsNeuroSense Advances PrimeC ALS Program and Cuts Costs in H1 20261M ago6KNRSN
Company AnnouncementsNeuroSense Therapeutics to Enact 1-for-20 Reverse Share Split on Nasdaq1M ago6KNRSN
Company AnnouncementsNeuroSense Shareholders Approve Flexible Reverse Share Split Authorization2M ago6KNRSN
Company AnnouncementsNeuroSense CEO Details Phase 3 ALS Trial Plans, Canada Filing and Nasdaq Compliance Efforts2M ago6KNRSN
Company AnnouncementsNeuroSense Advances PrimeC Toward December 2026 Health Canada Filing After Completing Pre-NDS Process2M ago6KNRSN
Company AnnouncementsNeuroSense Updates Capital on Demand Program After New F-3 Becomes Effective3M ago6KNRSN
Company AnnouncementsNeuroSense Therapeutics Calls August 26 Shareholder Vote on Wide-Range Reverse Share Split3M ago6KNRSNCompany AnnouncementsNeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS3M ago6KNRSN









